leflunomide has been researched along with Polychondritis, Chronic Atrophic in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Handler, RP | 1 |
| Koenig, AS | 1 |
| Abruzzo, JL | 1 |
2 other studies available for leflunomide and Polychondritis, Chronic Atrophic
| Article | Year |
|---|---|
Leflunomide for relapsing polychondritis: successful longterm treatment.
Topics: Anti-Inflammatory Agents; C-Reactive Protein; Cholestyramine Resin; Drug Therapy, Combination; Fever | 2006 |
Leflunomide induced fevers, thrombocytosis, and leukocytosis in a patient with relapsing polychondritis.
Topics: Anti-Inflammatory Agents; C-Reactive Protein; Cholestyramine Resin; Drug Therapy, Combination; Fever | 2002 |